BioSpace News Archive

Abalos Therapeutics announced the appointments of Dr. Klaus Binder as Chairman of the Board and Dr. Dethardt Müller as Chief Technology Officer to rapidly advance and build out the company’s drug discovery and manufacturing efforts for novel arenavirus-based cancer therapeutics.

JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences.

Boston Scientific Corporation generated sales of $2.905 billion during the fourth quarter of 2019.

Dr. McIvor, Chief Development Officer, to present on the Sleeping Beauty-Engineered B Lymphocytes ISP™ platform

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2019, prior to the open of the U.S. financial markets on Wednesday, February 12, 2020.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2019.

Centene Corporation announced that it has commenced an offering to sell $2,000,000,000 of senior notes due 2030, subject to market and other conditions.

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended January 3, 2020 on Wednesday, February 26, 2020 after the market close.

CURE debuts “CUREinside” quality mark on the packaging of ReLeaf Europe’s sublingual tinctures and new topical cream product lines

CODA Biotherapeutics, Inc., a preclinical-stage biopharmaceutical company developing a gene therapy-mediated chemogenetic platform, today announced it has completed the acquisition of Attenua, Inc.